JAMES TAYLOR, M.D.
Pediatric Hematology & Oncology Physician in WASHINGTON, District of Columbia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: JAMES TAYLOR, M.D. filed 454 Medicare Part D claims in 2023 across WASHINGTON, District of Columbia. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
JAMES TAYLOR, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
JAMES TAYLOR, M.D. at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in District of Columbia
How Pediatric Hematology & Oncology Physician compares to other specialties among District of Columbia providers
Pediatric Hematology & Oncology Physician share within District of Columbia
Pediatric Hematology & Oncology Physician is one of the more visible NUCC categories in District of Columbia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pediatric Hematology & Oncology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pediatric Hematology & Oncology Physician ABMS/AOA estimate
Est. board-certified rate (Pediatric Hematology & Oncology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pediatric Hematology & Oncology Physician US NPIs
Specialty board-certified rate — Pediatric Hematology & Oncology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JAMES TAYLOR, M.D. is a Pediatric Hematology & Oncology Physician provider practicing in WASHINGTON, District of Columbia, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1487689295. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
JAMES TAYLOR, M.D. appears in the CMS NPPES registry as a Pediatric Hematology & Oncology Physician provider holding M.D. credentials at 2041 GEORGIA AVE NW STE B&C, WASHINGTON, DC, 20060, with a listed phone of (202) 865-3118. NPI 1487689295 was issued on 07/11/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TAYLOR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 454 prescription claims written by this provider, covering 29 Medicare beneficiaries and totaling roughly $534K in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 40.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pediatric Hematology & Oncology Physician is a narrow specialty nationwide, with 2,568 enrolled providers across 52 states and an average of 92 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487689295 |
|---|---|
| Specialty | Pediatric Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/11/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JAMES TAYLOR, M.D.'s current license status, disciplinary history, and board certifications with the D.C. Board of Medicine in District of Columbia before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where JAMES TAYLOR, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JAMES TAYLOR, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$23
Largest payer
PFIZER INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 454 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 488
- Total Day Supply
- 10,915
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $495K
- Generic Drug Cost
- $39K
- Opioid Claims
- 184 (40.5% rate)
Patient Demographics
- Average Patient Age
- 46.2 years
- Avg HCC Risk Score
- 4.98
- Gender Split
- 48% female / 52% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Oxycodone Hcl | 47 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 40 |
| Adakveo Crizanlizumab-Tmca | 34 |
| Morphine Sulfate Er Morphine Sulfate | 31 |
| Hydroxyurea | 30 |
| Ibuprofen | 30 |
| Hydromorphone Hcl | 27 |
| Methadone Hcl | 24 |
| Zolpidem Tartrate | 21 |
| Oxycontin Oxycodone Hcl | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Hematology & Oncology Physician Overview
How JAMES TAYLOR, M.D. fits within the Pediatric Hematology & Oncology Physician landscape nationally.
JAMES TAYLOR, M.D.'s 454 claims are above the specialty average of 92.
Nearby Pediatric Hematology & Oncology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as TAYLOR.
Compare Pediatric Hematology & Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore District of Columbia
Frequently Asked Questions
What is JAMES TAYLOR, M.D.'s specialty? ▼
How much does JAMES TAYLOR, M.D. prescribe under Medicare Part D? ▼
Where is JAMES TAYLOR, M.D. located? ▼
What is JAMES TAYLOR, M.D.'s NPI number? ▼
Does JAMES TAYLOR, M.D. prescribe more brand-name or generic drugs? ▼
Does JAMES TAYLOR, M.D. prescribe opioids? ▼
How many Pediatric Hematology & Oncology Physician providers are there in the US? ▼
What drugs does JAMES TAYLOR, M.D. prescribe most often? ▼
Does JAMES TAYLOR, M.D. accept Medicare? ▼
How can I verify JAMES TAYLOR, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology